These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3144329)

  • 1. Treating hypertension in black compared with white non-insulin dependent diabetics: a double blind trial of verapamil and metoprolol.
    Cruickshank JK; Anderson NM; Wadsworth J; Young SM; Jepson E
    BMJ; 1988 Nov; 297(6657):1155-9. PubMed ID: 3144329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating hypertensive diabetics: a comparison of verapamil and metoprolol in black and white patients.
    Cruickshank JK; Anderson NM; Wadsworth J; Young SM; Jepson E
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S85-6. PubMed ID: 2455151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non-insulin-dependent diabetic patients with primary hypertension.
    Gall MA; Rossing P; Skøtt P; Hommel E; Mathiesen ER; Gerdes LU; Lauritzen M; Vølund A; Faergeman O; Beck-Nielsen H
    Am J Hypertens; 1992 May; 5(5 Pt 1):257-65. PubMed ID: 1581012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation.
    Dodson PM; Beevers M; Hallworth R; Webberley MJ; Fletcher RF; Taylor KG
    BMJ; 1989 Jan; 298(6668):227-30. PubMed ID: 2493869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
    Bakris GL; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Wright JT; Oakes R; Lukas MA; Anderson KM; Bell DS;
    JAMA; 2004 Nov; 292(18):2227-36. PubMed ID: 15536109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks.
    Saunders E; Weir MR; Kong BW; Hollifield J; Gray J; Vertes V; Sowers JR; Zemel MB; Curry C; Schoenberger J
    Arch Intern Med; 1990 Aug; 150(8):1707-13. PubMed ID: 2200382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans.
    Bakris GL; Mangrum A; Copley JB; Vicknair N; Sadler R
    Hypertension; 1997 Mar; 29(3):744-50. PubMed ID: 9052890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.
    Pollare T; Lithell H; Selinus I; Berne C
    BMJ; 1989 Apr; 298(6681):1152-7. PubMed ID: 2500169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetics with hypertension not controlled with ACE inhibitors: alternate therapies.
    Cleophas TJ; van Ouwerkerk BM; van der Meulen J; Zwinderman AH
    Angiology; 2001 Jul; 52(7):469-75. PubMed ID: 11515986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.
    Ostman J; Asplund K; Bystedt T; Dahlöf B; Jern S; Kjellström T; Lithell H
    J Intern Med; 1998 Aug; 244(2):95-107. PubMed ID: 10095796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension.
    Jawa A; Nachimuthu S; Pendergrass M; Asnani S; Fonseca V
    J Diabetes Complications; 2008; 22(5):303-8. PubMed ID: 18413195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systolic time intervals as possible predictors of pressure response to sustained beta-adrenergic blockade in arterial hypertension. A within-patient, placebo-controlled study.
    Verdecchia P; Brignole M; Delfino G; Queirolo C; De Marchi G; Bertulla A
    Hypertension; 1983; 5(1):140-6. PubMed ID: 6336719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
    Frishman WH; Michelson EL; Johnson BF; Poland MP
    Am J Med; 1983 Oct; 75(4A):54-67. PubMed ID: 6356900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Verapamil versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
    BMJ; 1989 Oct; 299(6704):881-6. PubMed ID: 2510877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
    Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
    Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 study.
    Weber MA; Mansfield TA; Cain VA; Iqbal N; Parikh S; Ptaszynska A
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):211-220. PubMed ID: 26620248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of felodipine on urinary albumin excretion and metabolic control in hypertensive non-insulin-dependent diabetics.
    Schmitz A; Pedersen MM; Mogensen CE
    Am J Hypertens; 1990 Aug; 3(8 Pt 1):611-7. PubMed ID: 2222952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.